Neuberger Berman Group LLC Buys 450,648 Shares of Revvity Inc. $RVTY

Neuberger Berman Group LLC grew its stake in shares of Revvity Inc. (NYSE:RVTY) by 4,598.9% during the third quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 460,447 shares of the company’s stock after buying an additional 450,648 shares during the period. Neuberger Berman Group LLC owned 0.41% of Revvity worth $40,358,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in the stock. EdgePoint Investment Group Inc. raised its stake in Revvity by 26.7% during the 2nd quarter. EdgePoint Investment Group Inc. now owns 6,789,660 shares of the company’s stock worth $656,696,000 after acquiring an additional 1,428,813 shares during the period. Invesco Ltd. lifted its holdings in Revvity by 25.8% during the second quarter. Invesco Ltd. now owns 2,207,202 shares of the company’s stock valued at $213,481,000 after purchasing an additional 452,343 shares in the last quarter. Dimensional Fund Advisors LP boosted its position in shares of Revvity by 39.0% in the third quarter. Dimensional Fund Advisors LP now owns 2,125,957 shares of the company’s stock worth $186,307,000 after purchasing an additional 596,436 shares during the period. Primecap Management Co. CA increased its stake in shares of Revvity by 18.7% in the second quarter. Primecap Management Co. CA now owns 1,359,641 shares of the company’s stock worth $131,504,000 after purchasing an additional 214,056 shares in the last quarter. Finally, Norges Bank purchased a new stake in shares of Revvity in the second quarter worth $124,574,000. 86.65% of the stock is currently owned by institutional investors.

Revvity Price Performance

Shares of NYSE:RVTY opened at $91.28 on Friday. The company has a debt-to-equity ratio of 0.36, a quick ratio of 1.40 and a current ratio of 1.68. The firm has a fifty day moving average price of $103.15 and a 200 day moving average price of $96.61. Revvity Inc. has a fifty-two week low of $81.36 and a fifty-two week high of $120.39. The firm has a market cap of $10.21 billion, a price-to-earnings ratio of 43.88, a P/E/G ratio of 2.05 and a beta of 1.10.

Revvity (NYSE:RVTY) last posted its earnings results on Monday, February 2nd. The company reported $1.70 earnings per share for the quarter, beating the consensus estimate of $1.55 by $0.15. The company had revenue of $772.06 million during the quarter, compared to analysts’ expectations of $759.81 million. Revvity had a net margin of 8.45% and a return on equity of 7.92%. Revvity’s quarterly revenue was up 5.9% on a year-over-year basis. During the same period last year, the company posted $1.42 earnings per share. Revvity has set its FY 2026 guidance at 5.350-5.450 EPS. As a group, sell-side analysts expect that Revvity Inc. will post 4.94 earnings per share for the current fiscal year.

Revvity Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Friday, May 8th. Stockholders of record on Friday, April 17th will be given a dividend of $0.07 per share. The ex-dividend date is Friday, April 17th. This represents a $0.28 dividend on an annualized basis and a dividend yield of 0.3%. Revvity’s dividend payout ratio (DPR) is presently 13.46%.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on RVTY shares. Bank of America cut shares of Revvity from a “buy” rating to a “neutral” rating and set a $110.00 target price on the stock. in a research note on Monday, December 15th. Evercore increased their price target on Revvity from $112.00 to $118.00 and gave the stock an “outperform” rating in a research note on Tuesday, February 3rd. Wall Street Zen raised Revvity from a “hold” rating to a “buy” rating in a report on Saturday, February 28th. Wells Fargo & Company boosted their price objective on Revvity from $107.00 to $110.00 and gave the company an “equal weight” rating in a research report on Tuesday, February 3rd. Finally, Barclays upped their price objective on Revvity from $115.00 to $118.00 and gave the stock an “overweight” rating in a research note on Tuesday, February 3rd. Five research analysts have rated the stock with a Buy rating and nine have given a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $113.67.

Revvity Company Profile

Revvity, Inc is a global provider of technology-enabled solutions for the life sciences, diagnostics and applied markets. The company develops and supplies a range of products and services, including reagents and consumables, laboratory instruments, workflow automation, software analytics and technical support. Its portfolio supports applications in drug discovery, genomics, cell biology research, environmental and food safety testing, industrial quality control and clinical diagnostics.

Tracing its heritage to Perkin-Elmer, founded in 1937, Revvity began trading on the New York Stock Exchange under the ticker symbol RVTY in January 2024 following a corporate rebranding.